Australian Government - Department of Health

Medical Services Advisory Committee (MSAC)

1377- Optical coherence tomography (OCT) for retinal assessment in the presence of diabetic macular oedema (DMO) for access to treatment with dexamethasone posterior segment drug delivery system

The documents on this page may not be accessible, should you require assistance accessing the information please contact the MSAC Secretariat at msac.secretariat@health.gov.au
Application Number1377
Application NameOptical coherence tomography (OCT) for retinal assessment in the presence of diabetic macular oedema (DMO) for access to treatment with dexamethasone posterior segment drug delivery system
Description of Medical ServiceOCT is a non-invasive ophthalmic imaging technique, which provides high-resolution cross-sectional images of the macula, allowing identification of changes due to ophthalmologic conditions. OCT is based on the light reflectance properties of the tissue and provides tissue morphology imagery at higher resolution (better than 10 Ám) than other imaging modalities such as MRI or ultrasound.

OCT is intended to be used for diagnosis and monitoring of retinal diseases in a specialist ophthalmologic setting. It is used in conjunction with visual acuity assessments, clinical examination and fluorescein angiography.
Description of Medical ConditionDiabetic retinopathy is defined as the presence of typical retinal microvascular lesions in persons with diabetes mellitus. DMO, a specific form of diabetic retinopathy, is usually defined as a retinal thickening within two disc diameters of the macula.

DMO is associated with damage to the microvasculature, including retinal haemorrhages, exudates, micro-aneurysms, microvascular abnormalities and areas of capillary closure; leading to the accumulation of fluid and serum macromolecules in the intercellular space. As a result, thickening of the retina and fovea can occur, leading to disturbances in visual acuity.
Consultation Protocol27 June 2014 - 18 July 2014

Consultation Protocol (PDF 530 KB)
Consultation Protocol (Word 844 KB)

Survey and Feedback Form - 1377 (PDF 36 KB)
Survey and Feedback Form - 1377 (Word 108 KB)

Final ProtocolFinal Protocol (PDF 533 KB)
Final Protocol (Word 860 KB)
Reports-
MSAC OutcomesApril 2015 MSAC Consideration:
Public Summary Document (PDF 463 KB)
Public Summary Document (Word 1449 KB)

March 2016 MSAC Consideration:
Public Summary Document (PDF 133 KB)
Public Summary Document (Word 75 KB)

OCT broader implementation issues - MSAC's advice to the Minister:
OCT broader implementation issues (PDF 66 KB)
OCT broader implementation issues (Word 66 KB)

Meetings for this Application

Meeting Type:Date:
PASC16 to 17 April 2014
14 to 15 August 2014
ESC 12 to 13 February 2015
MSAC 1 to 2 April 2015
30 to 31 March 2016

Page currency, Latest update: 08 June, 2016